Resolvin E1 reduces hepatic fibrosis in mice with Schistosoma japonicum infection

Experimental and Therapeutic Medicine

Volumn 7, Issue 6, 2014, Pages 1481-1485

  Qiu, Wenhong ^a   Guo, Kaiwen ^b   Yi, Luyang ^a   Gong, Yeli ^a   Huang, Lixia ^a   Zhong, Wei ^a  

^a JIANGHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Anti inflammatory; Hepatic fibrosis; Immune adjustment; Infection; Resolvin E1; Schistosoma japonicum

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COLLAGEN TYPE 4; GAMMA INTERFERON; HYALURONIC ACID; LAMININ; LIVER PROTECTIVE AGENT; MESSENGER RNA; PROCOLLAGEN; RESOLVIN E1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRANULOMA; LIVER NECROSIS; LIVER PROTECTION; MOUSE; NONHUMAN; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHISTOSOMIASIS JAPONICA; WESTERN BLOTTING;

EID: 84898463769     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1641     Document Type: Article

References (21)

1. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R and Wynn TA: Immunopathology of schistoso-miasis. Immunol Cell Biol 85: 148-154, 2007.
2. Chitsulo L, Engels D, Mont resor A a nd Savioli L: The global status of schistosomiasis and its control. Acta Trop 77: 41-51, 2000.
3. Pearce EJ and MacDonald AS: The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511, 2002.
4. Fabre V, Wu H, PondTor S, Coutinho H, Acosta L, Jiz M, Olveda R, Cheng L, White ES, Jarilla B, McGarvey ST, Friedman JF and Kurtis JD: Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis 203: 707-714, 2011.
5. Zou WL, Yang Z, Zang YJ, Li DJ, Liang ZP and Shen ZY: Inhibitory effects of prostaglandin E1 on activation of hepatic stellate cells in rabbits with schistosomiasis. Hepatobiliary Pancreat Dis Int 6: 176-181, 2007.
6. Iredale JP: Models of liver fbrosis: exploring the dynamic nature of infammation and repair in a solid organ. J Clin Invest 117: 539-548, 2007.
7. Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke TE and Serhan CN: Resolvin E1 receptor activation signals phosphory-lation and phagocytosis. J Biol Chem. 285: 3451-3461, 2010.
8. WHO Expert Committee: Prevention and control of schistoso-miasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser 912, 2002.
9. Collins C, Xu J and Tang S: Schistosomiasis control and the health system in P.R. China. Infect Dis Poverty 8(1), 2012.
10. Gryseels B, Polman K, Clerinx J and Kestens L: Human schisto-somiasis. Lancet 368: 1106-1118, 2006.
11. Coutinho HM, Acosta LP, Wu HW, McGarvey ST, Su L, Langdon GC, Jiz MA, Jarilla B, Olveda RM, Friedman JF and Kurtis JD: Th2 cytokines are associated with persistent hepatic fbrosis in human Schistosoma japonicum infection. J Infect Dis 195: 288-295, 2007.
12. MacDonald TT: Decoy receptor springs to life and eases fbrosis. Nat Med 12: 13-14, 2006.
13. Fichtner-Feigl S, Strober W, Kawakami K, Puri PK and Kitani A: IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fbrosis. Nat Med 12: 99-106, 2006.
14. Bonnard P, Remoué F, Schacht AM, Pialoux G and Riveau G: Association between serum cytokine profles and schistosomia-sisrelated hepatic fbrosis: infection by Schistosoma japonicum versus S. mansoni. J Infect Dis 193: 748-750, 2006.
15. Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, Dessein H, Montero F, Elwali NE, Saeed OK, Magzoub M and Dessein AJ: Cytokine regulation of periportal fbrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fbrosis and TNF-alpha with aggravation of disease. J Immunol 169: 929-936, 2002.
16. Booth M, Mwatha JK, Joseph S, Jones FM, Kadzo H, Ireri E, Kazibwe F, Kemijumbi J, Kariuki C, Kimani G, Ouma JH, Kabatereine NB, Vennervald BJ and Dunne DW: Periportal fbrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J Immunol 172: 1295-1303, 2004.
17. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N and Gronert K: Novel functional sets of lipid-derived mediators with antiinfammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinfammatory drugs and transcellular processing. J Exp Med 192: 1197-1204, 2000.
18. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G and Moussignac RL: Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinfammation signals. J Exp Med 196: 1025-1037, 2002.
19. Serhan CN: Resolution phase of infammation: novel endogenous anti-infammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25: 101-137, 2007.
20. Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D, Hellstrom A, Kang JX, Chew EY, Salem N Jr, Serhan CN, Smith LE: Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13: 868-873, 2007.
21. Schwab JM, Chiang N, Arita M and Serhan CN: Nature 447: 869-874, 2007.